Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil

Trifluridine/tipiracil (FTD/TPI) is an oral anticancer agent used as a third- or later-line treatment for patients with metastatic gastric cancer/gastroesophageal junction cancer (mGC/GEJC). The C-reactive protein-to-serum albumin ratio (CAR) is an inflammation-based prognostic marker in gastric can...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Itaru, Kano, Kazuki, Onuma, Shizune, Suematsu, Hideaki, Nagasawa, Shinsuke, Kanematsu, Kyohei, Furusawa, Kyoko, Hamaguchi, Tomomi, Watanabe, Mamoru, Hayashi, Kei, Furuta, Mitsuhiro, Inokuchi, Yasuhiro, Machida, Nozomu, Aoyama, Toru, Yamada, Takanobu, Rino, Yasushi, Ogata, Takashi, Oshima, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303086/
https://www.ncbi.nlm.nih.gov/pubmed/37373912
http://dx.doi.org/10.3390/jpm13060923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303086/
https://www.ncbi.nlm.nih.gov/pubmed/37373912
http://dx.doi.org/10.3390/jpm13060923

Ejemplares similares